3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine

C88H99BrN24O10 — CID 161249606

IUPAC3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine
SMILESCC(Cn1cc2c(N)nc3cc(-c4ccnn4C4CCCCO4)ccc3c2n1)C(=O)O.CC(Cn1cc2c(N)nc3cc(C4=CC=NC4)ccc3c2n1)C(=O)N(C)C.COC(=O)C(C)Cn1cc2c(N)nc3cc(-c4ccnn4C4CCCCO4)ccc3c2n1.COC(=O)[C@@H](C)CBr.Nc1nc2cc(-c3ccnn3C3CCCCO3)ccc2c2[nH]ncc12
InChIInChI=1S/C23H26N6O3.C22H24N6O3.C20H22N6O.C18H18N6O.C5H9BrO2/c1-14(23(30)31-2)12-28-13-17-21(27-28)16-7-6-15(11-18(16)26-22(17)24)19-8-9-25-29(19)20-5-3-4-10-32-20;1-13(22(29)30)11-27-12-16-20(26-27)15-6-5-14(10-17(15)25-21(16)23)18-7-8-24-28(18)19-4-2-3-9-31-19;1-12(20(27)25(2)3)10-26-11-16-18(24-26)15-5-4-13(14-6-7-22-9-14)8-17(15)23-19(16)21;19-18-13-10-20-23-17(13)12-5-4-11(9-14(12)22-18)15-6-7-21-24(15)16-3-1-2-8-25-16;1-4(3-6)5(7)8-2/h6-9,11,13-14,20H,3-5,10,12H2,1-2H3,(H2,24,26);5-8,10,12-13,19H,2-4,9,11H2,1H3,(H2,23,25)(H,29,30);4-8,11-12H,9-10H2,1-3H3,(H2,21,23);4-7,9-10,16H,1-3,8H2,(H2,19,22)(H,20,23);4H,3H2,1-2H3/t;;;;4-/m....0/s1
InChIKeyVBCBUXNWOVZWIR-GACGRETASA-N
MW1732.82 g/mol
LogP13.79
Rot. Bonds18

About 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine

3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine (PubChem CID 161249606) has the molecular formula C88H99BrN24O10 and a molecular weight of 1732.82 g/mol. Its IUPAC name is 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine.

Molecular Properties

Compound Name3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine
PubChem CID161249606
Molecular FormulaC88H99BrN24O10
Molecular Weight1732.82 g/mol
Exact Mass1730.72
IUPAC Name3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine
SMILESCC(Cn1cc2c(N)nc3cc(-c4ccnn4C4CCCCO4)ccc3c2n1)C(=O)O.CC(Cn1cc2c(N)nc3cc(C4=CC=NC4)ccc3c2n1)C(=O)N(C)C.COC(=O)C(C)Cn1cc2c(N)nc3cc(-c4ccnn4C4CCCCO4)ccc3c2n1.COC(=O)[C@@H](C)CBr.Nc1nc2cc(-c3ccnn3C3CCCCO3)ccc2c2[nH]ncc12
InChIInChI=1S/C23H26N6O3.C22H24N6O3.C20H22N6O.C18H18N6O.C5H9BrO2/c1-14(23(30)31-2)12-28-13-17-21(27-28)16-7-6-15(11-18(16)26-22(17)24)19-8-9-25-29(19)20-5-3-4-10-32-20;1-13(22(29)30)11-27-12-16-20(26-27)15-6-5-14(10-17(15)25-21(16)23)18-7-8-24-28(18)19-4-2-3-9-31-19;1-12(20(27)25(2)3)10-26-11-16-18(24-26)15-5-4-13(14-6-7-22-9-14)8-17(15)23-19(16)21;19-18-13-10-20-23-17(13)12-5-4-11(9-14(12)22-18)15-6-7-21-24(15)16-3-1-2-8-25-16;1-4(3-6)5(7)8-2/h6-9,11,13-14,20H,3-5,10,12H2,1-2H3,(H2,24,26);5-8,10,12-13,19H,2-4,9,11H2,1H3,(H2,23,25)(H,29,30);4-8,11-12H,9-10H2,1-3H3,(H2,21,23);4-7,9-10,16H,1-3,8H2,(H2,19,22)(H,20,23);4H,3H2,1-2H3/t;;;;4-/m....0/s1
InChIKeyVBCBUXNWOVZWIR-GACGRETASA-N
XLogP13.79
TPSA441.50 Ų
H-Bond Donors6
H-Bond Acceptors31
Rotatable Bonds18
Heavy Atoms123
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001732.82
LogP ≤ 513.79
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine?
The IUPAC name of 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine (CID 161249606) is 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine.
What is the SMILES notation for 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine?
The canonical SMILES for 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine is CC(Cn1cc2c(N)nc3cc(-c4ccnn4C4CCCCO4)ccc3c2n1)C(=O)O.CC(Cn1cc2c(N)nc3cc(C4=CC=NC4)ccc3c2n1)C(=O)N(C)C.COC(=O)C(C)Cn1cc2c(N)nc3cc(-c4ccnn4C4CCCCO4)ccc3c2n1.COC(=O)[C@@H](C)CBr.Nc1nc2cc(-c3ccnn3C3CCCCO3)ccc2c2[nH]ncc12.
What is the InChIKey of 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine?
The InChIKey is VBCBUXNWOVZWIR-GACGRETASA-N. The full InChI is InChI=1S/C23H26N6O3.C22H24N6O3.C20H22N6O.C18H18N6O.C5H9BrO2/c1-14(23(30)31-2)12-28-13-17-21(27-28)16-7-6-15(11-18(16)26-22(17)24)19-8-9-25-29(19)20-5-3-4-10-32-20;1-13(22(29)30)11-27-12-16-20(26-27)15-6-5-14(10-17(15)25-21(16)23)18-7-8-24-28(18)19-4-2-3-9-31-19;1-12(20(27)25(2)3)10-26-11-16-18(24-26)15-5-4-13(14-6-7-22-9-14)8-17(15)23-19(16)21;19-18-13-10-20-23-17(13)12-5-4-11(9-14(12)22-18)15-6-7-21-24(15)16-3-1-2-8-25-16;1-4(3-6)5(7)8-2/h6-9,11,13-14,20H,3-5,10,12H2,1-2H3,(H2,24,26);5-8,10,12-13,19H,2-4,9,11H2,1H3,(H2,23,25)(H,29,30);4-8,11-12H,9-10H2,1-3H3,(H2,21,23);4-7,9-10,16H,1-3,8H2,(H2,19,22)(H,20,23);4H,3H2,1-2H3/t;;;;4-/m....0/s1.
What are the key properties of 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine?
3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine has a molecular weight of 1732.82 g/mol, XLogP of 13.79, 18 rotatable bonds, 6 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoic acid;3-[4-amino-7-(2H-pyrrol-3-yl)pyrazolo[4,3-c]quinolin-2-yl]-N,N,2-trimethylpropanamide;methyl 3-[4-amino-7-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[4,3-c]quinolin-2-yl]-2-methylpropanoate;methyl (2R)-3-bromo-2-methylpropanoate;7-[2-(oxan-2-yl)pyrazol-3-yl]-1H-pyrazolo[4,5-c]quinolin-4-amine is sourced from PubChem (CID 161249606), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).